BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 30482236)

  • 1. Long noncoding RNA LINC00511 contributes to breast cancer tumourigenesis and stemness by inducing the miR-185-3p/E2F1/Nanog axis.
    Lu G; Li Y; Ma Y; Lu J; Chen Y; Jiang Q; Qin Q; Zhao L; Huang Q; Luo Z; Huang S; Wei Z
    J Exp Clin Cancer Res; 2018 Nov; 37(1):289. PubMed ID: 30482236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA FEZF1-AS1 promotes breast cancer stemness and tumorigenesis via targeting miR-30a/Nanog axis.
    Zhang Z; Sun L; Zhang Y; Lu G; Li Y; Wei Z
    J Cell Physiol; 2018 Nov; 233(11):8630-8638. PubMed ID: 29797562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LINC00511 Promotes Osteosarcoma Tumorigenesis and Invasiveness through the miR-185-3p/E2F1 Axis.
    Xu J; Chen G; Zhang Y; Huang Z; Cheng X; Gu H; Xia J; Yin X
    Biomed Res Int; 2020; 2020():1974506. PubMed ID: 32964019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA LUCAT1/miR-5582-3p/TCF7L2 axis regulates breast cancer stemness via Wnt/β-catenin pathway.
    Zheng A; Song X; Zhang L; Zhao L; Mao X; Wei M; Jin F
    J Exp Clin Cancer Res; 2019 Jul; 38(1):305. PubMed ID: 31300015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA LINC00511 promoted cell proliferation and invasion via regulating miR-124-3p/EZH2 pathway in gastric cancer.
    Huang HG; Tang XL; Huang XS; Zhou L; Hao YG; Zheng YF
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4232-4245. PubMed ID: 32373959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linc00511 acts as a competing endogenous RNA to regulate VEGFA expression through sponging hsa-miR-29b-3p in pancreatic ductal adenocarcinoma.
    Zhao X; Liu Y; Li Z; Zheng S; Wang Z; Li W; Bi Z; Li L; Jiang Y; Luo Y; Lin Q; Fu Z; Rufu C
    J Cell Mol Med; 2018 Jan; 22(1):655-667. PubMed ID: 28984028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA SPRY4-IT1 regulates breast cancer cell stemness through competitively binding miR-6882-3p with TCF7L2.
    Song X; Zhang X; Wang X; Chen L; Jiang L; Zheng A; Zhang M; Zhao L; Wei M
    J Cell Mol Med; 2020 Jan; 24(1):772-784. PubMed ID: 31736268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA NNT-AS1 sponges miR-424/E2F1 to promote the tumorigenesis and cell cycle progression of gastric cancer.
    Chen B; Zhao Q; Guan L; Lv H; Bie L; Huang J; Chen XB
    J Cell Mol Med; 2018 Oct; 22(10):4751-4759. PubMed ID: 30006956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA LINC00511 involves in breast cancer recurrence and radioresistance by regulating STXBP4 expression via miR-185.
    Liu L; Zhu Y; Liu AM; Feng Y; Chen Y
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7457-7468. PubMed ID: 31539133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [LincRNA-ROR functions as a ceRNA to regulate Oct4, Sox2, and Nanog expression by sponging miR-145 and its effect on biologic characteristics of colonic cancer stem cells].
    Yan ZY; Sun XC
    Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):284-290. PubMed ID: 29690669
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased long noncoding RNA LINC00511 is correlated with poor prognosis and contributes to cell proliferation and metastasis by modulating miR-424 in hepatocellular carcinoma.
    Wang RP; Jiang J; Jiang T; Wang Y; Chen LX
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3291-3301. PubMed ID: 31081082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STAT3-induced HLA-F-AS1 promotes cell proliferation and stemness characteristics in triple negative breast cancer cells by upregulating TRABD.
    Wu D; Jia H; Zhang Z; Li S
    Bioorg Chem; 2021 Apr; 109():104722. PubMed ID: 33618253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas9-mediated LINC00511 knockout strategies, increased apoptosis of breast cancer cells via suppressing antiapoptotic genes.
    Azadbakht N; Doosti A; Jami MS
    Biol Proced Online; 2022 Jul; 24(1):8. PubMed ID: 35790898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroR-760 suppresses cancer stem cell subpopulation and breast cancer cell proliferation and metastasis: By down-regulating NANOG.
    Han ML; Wang F; Gu YT; Pei XH; Ge X; Guo GC; Li L; Duan X; Zhu MZ; Wang YM
    Biomed Pharmacother; 2016 May; 80():304-310. PubMed ID: 27133070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AP2γ mediated downregulation of lncRNA LINC00511 as a ceRNA suppresses trophoblast invasion by regulating miR-29b-3p/Cyr61 axis.
    Quan X; Zhao M; Yang X; Zhu Y; Tian X
    Biomed Pharmacother; 2019 Dec; 120():109269. PubMed ID: 31542614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA HOTTIP facilitates the stemness of breast cancer via regulation of miR-148a-3p/WNT1 pathway.
    Han L; Yan Y; Zhao L; Liu Y; Lv X; Zhang L; Zhao Y; Zhao H; He M; Wei M
    J Cell Mol Med; 2020 Jun; 24(11):6242-6252. PubMed ID: 32307830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small peptide LINC00511-133aa encoded by LINC00511 regulates breast cancer cell invasion and stemness through the Wnt/β-catenin pathway.
    Tan Z; Zhao L; Huang S; Jiang Q; Wei Y; Wu JL; Zhang Z; Li Y
    Mol Cell Probes; 2023 Jun; 69():101913. PubMed ID: 37068562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LINC00511 knockdown enhances paclitaxel cytotoxicity in breast cancer via regulating miR-29c/CDK6 axis.
    Zhang H; Zhao B; Wang X; Zhang F; Yu W
    Life Sci; 2019 Jul; 228():135-144. PubMed ID: 31047896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ROR functions as a ceRNA to regulate Nanog expression by sponging miR-145 and predicts poor prognosis in pancreatic cancer.
    Gao S; Wang P; Hua Y; Xi H; Meng Z; Liu T; Chen Z; Liu L
    Oncotarget; 2016 Jan; 7(2):1608-18. PubMed ID: 26636540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LINC00511 as a ceRNA promotes cell malignant behaviors and correlates with prognosis of hepatocellular carcinoma patients by modulating miR-195/EYA1 axis.
    Hu WY; Wei HY; Li KM; Wang RB; Xu XQ; Feng R
    Biomed Pharmacother; 2020 Jan; 121():109642. PubMed ID: 31731191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.